Skip to content
Disclosery

EXANE DERIVATIVES: PAYC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PAYC, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 303 PAYC shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 303 shares
    Change vs previous 13F -557 shares

    0.05% of the 13F portfolio, value $84,859.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 860 shares
    Change vs previous 13F +91 shares

    0.08% of the 13F portfolio, value $297,868.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 769 shares
    Change vs previous 13F +519 shares

    0.08% of the 13F portfolio, value $319,270.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 250 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $123,933.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 250 shares
    Change vs previous 13F +100 shares

    0.02% of the 13F portfolio, value $93,003.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 150 shares
    Change vs previous 13F 0 shares

    0.02% of the 13F portfolio, value $55,507.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 150 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $67,834.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).